Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials

Linda G Mellbin; Deepak L Bhatt; Jens-Peter David; Kathrine Ekström; Mark C Petrie; Søren Rasmussen; Tina Vilsbøll

doi:10.1093/eurheartj/ehae028

Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials

Linda G Mellbin, Deepak L Bhatt, Jens-Peter David, Kathrine Ekström, Mark C Petrie, Søren Rasmussen, Tina Vilsbøll

Steno Diabetes Center Copenhagen

9 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	European Heart Journal
Vol/bind	45
Udgave nummer	15
Sider (fra-til)	1371-1374
Antal sider	4
ISSN	0195-668X
DOI	https://doi.org/10.1093/eurheartj/ehae028
Status	Udgivet - 14 apr. 2024

Adgang til dokumentet

10.1093/eurheartj/ehae028

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{98bea9c85dfe44ceb52f11813f16878c,

title = "Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials",

keywords = "Cardiovascular System, Diabetes Mellitus, Type 2/complications, Glucagon-Like Peptides/therapeutic use, Glycated Hemoglobin, Humans, Hypoglycemic Agents/therapeutic use, Type 2 diabetes, HbA, Semaglutide, Major adverse cardiovascular events, Glucagon-like peptide-1 receptor agonist, PIONEER 6, Cardiovascular outcomes trial, Post hoc analysis, SUSTAIN 6",

author = "Mellbin, {Linda G} and Bhatt, {Deepak L} and Jens-Peter David and Kathrine Ekstr{\"o}m and Petrie, {Mark C} and S{\o}ren Rasmussen and Tina Vilsb{\o}ll",

year = "2024",

month = apr,

day = "14",

doi = "10.1093/eurheartj/ehae028",

language = "English",

volume = "45",

pages = "1371--1374",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "15",

}

TY - JOUR

T1 - Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes

T2 - the SUSTAIN 6 and PIONEER 6 trials

AU - Mellbin, Linda G

AU - Bhatt, Deepak L

AU - David, Jens-Peter

AU - Ekström, Kathrine

AU - Petrie, Mark C

AU - Rasmussen, Søren

AU - Vilsbøll, Tina

PY - 2024/4/14

Y1 - 2024/4/14

KW - Cardiovascular System

KW - Diabetes Mellitus, Type 2/complications

KW - Glucagon-Like Peptides/therapeutic use

KW - Glycated Hemoglobin

KW - Humans

KW - Hypoglycemic Agents/therapeutic use

KW - Type 2 diabetes

KW - HbA

KW - Semaglutide

KW - Major adverse cardiovascular events

KW - Glucagon-like peptide-1 receptor agonist

KW - PIONEER 6

KW - Cardiovascular outcomes trial

KW - Post hoc analysis

KW - SUSTAIN 6

UR - http://www.scopus.com/inward/record.url?scp=85190494167&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehae028

DO - 10.1093/eurheartj/ehae028

M3 - Journal article

C2 - 38416593

SN - 0195-668X

VL - 45

SP - 1371

EP - 1374

JO - European Heart Journal

JF - European Heart Journal

IS - 15

ER -